{"transactions":[{"id":904819,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-13T21:02:10.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":51714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on February 15, 2027, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":100934.268,"source":{"system":"sec-edgar","filing":"0001628280-26-008077","document":"wk-form4_1771016527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026008077/wk-form4_1771016527.xml","form_type":"4"}},{"id":921279,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-03T23:23:46.000Z","date":"2026-01-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":5182,"price":20.54,"value":106438.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award."}],"balance_after":49220.268,"source":{"system":"sec-edgar","filing":"0001628280-26-005154","document":"wk-form4_1770161023.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026005154/wk-form4_1770161023.xml","form_type":"4"}},{"id":945854,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-06T22:30:28.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":402.268,"price":10.763,"value":4329.610484,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock acquired under the issuer's employee stock purchase plan in December 2025."}],"balance_after":54402.268,"source":{"system":"sec-edgar","filing":"0001628280-26-000964","document":"wk-form4_1767738624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026000964/wk-form4_1767738624.xml","form_type":"4"}},{"id":1284014,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T23:25:33.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":99500,"price":26.59,"value":2645705.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments\nover the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":99500,"derivative":{"exercise_price":26.59,"expiration_date":"2036-02-04","underlying":"Common Stock","underlying_shares":99500},"source":{"system":"sec-edgar","filing":"0001396814-25-000030","document":"wk-form4_1738711527.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000030/wk-form4_1738711527.xml","form_type":"4"}},{"id":1284013,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-02-04T23:25:33.000Z","date":"2025-02-01","kind":"grant","planned":false,"acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on February 1, 2026, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":54000,"source":{"system":"sec-edgar","filing":"0001396814-25-000030","document":"wk-form4_1738711527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681425000030/wk-form4_1738711527.xml","form_type":"4"}},{"id":1359998,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, HEAD OF COMMERCIAL"}}],"security":"Restricted Stock Units","published_at":"2024-11-20T01:43:42.000Z","date":"2024-11-17","kind":"exercise","planned":false,"acquired":false,"shares":9913,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."}],"balance_after":9913,"derivative":{"underlying":"Common Stock","underlying_shares":9913},"source":{"system":"sec-edgar","filing":"0001415889-24-027294","document":"form4-11202024_011138.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924027294/form4-11202024_011138.xml","form_type":"4"}},{"id":1359997,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, HEAD OF COMMERCIAL"}}],"security":"Restricted Stock Units","published_at":"2024-11-20T01:43:42.000Z","date":"2024-11-17","kind":"exercise","planned":false,"acquired":false,"shares":9913,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."}],"balance_after":9913,"derivative":{"underlying":"Common Stock","underlying_shares":9913},"source":{"system":"sec-edgar","filing":"0001415889-24-027294","document":"form4-11202024_011138.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924027294/form4-11202024_011138.xml","form_type":"4"}},{"id":1359996,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, HEAD OF COMMERCIAL"}}],"security":"Common Stock","published_at":"2024-11-20T01:43:42.000Z","date":"2024-11-19","kind":"sale","planned":false,"acquired":false,"shares":10329,"price":16.81,"value":173630.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.7947 to $16.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":62105,"source":{"system":"sec-edgar","filing":"0001415889-24-027294","document":"form4-11202024_011138.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924027294/form4-11202024_011138.xml","form_type":"4"}},{"id":1359995,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, HEAD OF COMMERCIAL"}}],"security":"Common Stock","published_at":"2024-11-20T01:43:42.000Z","date":"2024-11-17","kind":"exercise","planned":false,"acquired":true,"shares":9913,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":72434,"source":{"system":"sec-edgar","filing":"0001415889-24-027294","document":"form4-11202024_011138.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924027294/form4-11202024_011138.xml","form_type":"4"}},{"id":1359994,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, HEAD OF COMMERCIAL"}}],"security":"Common Stock","published_at":"2024-11-20T01:43:42.000Z","date":"2024-11-17","kind":"exercise","planned":false,"acquired":true,"shares":9913,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 431 shares of the Issuer's common stock acquired by the reporting person on November 15, 2024 pursuant to an employee stock purchase plan."}],"balance_after":62521,"source":{"system":"sec-edgar","filing":"0001415889-24-027294","document":"form4-11202024_011138.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924027294/form4-11202024_011138.xml","form_type":"4"}},{"id":1428118,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, HEAD OF COMMERCIAL"}}],"security":"Common Stock","published_at":"2024-08-20T22:43:23.000Z","date":"2024-08-19","kind":"sale","planned":false,"acquired":false,"shares":9534,"price":15.28,"value":145679.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of performance stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.28 to $15.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":52177,"source":{"system":"sec-edgar","filing":"0001415889-24-021726","document":"form4-08202024_100820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924021726/form4-08202024_100820.xml","form_type":"4"}},{"id":1428117,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, HEAD OF COMMERCIAL"}}],"security":"Common Stock","published_at":"2024-08-20T22:43:23.000Z","date":"2024-08-16","kind":"grant","planned":false,"acquired":true,"shares":13629,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents acquisition of the Issuer's common stock upon vesting of the performance stock units granted to the Reporting Person on May 1, 2023 at 50% of target."}],"balance_after":61711,"source":{"system":"sec-edgar","filing":"0001415889-24-021726","document":"form4-08202024_100820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924021726/form4-08202024_100820.xml","form_type":"4"}},{"id":1428116,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, HEAD OF COMMERCIAL"}}],"security":"Common Stock","published_at":"2024-08-20T22:43:23.000Z","date":"2024-08-16","kind":"grant","planned":false,"acquired":true,"shares":5024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents acquisition of the Issuer's common stock upon vesting of the performance stock units granted to the Reporting Person on April 5, 2022 at incremental 25% of target. Together with the vesting on March 25, 2024, the performance stock units have vested at 75% of target."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 925 shares acquired by the Reporting Person under the Issuer's Employee Stock Purchase Plan on May 15, 2024."}],"balance_after":48082,"source":{"system":"sec-edgar","filing":"0001415889-24-021726","document":"form4-08202024_100820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924021726/form4-08202024_100820.xml","form_type":"4"}},{"id":1529064,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, HEAD OF COMMERCIAL"}}],"security":"Restricted Stock Units","published_at":"2024-05-03T22:00:48.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":false,"shares":6814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."}],"balance_after":20445,"derivative":{"underlying":"Common Stock","underlying_shares":6814},"source":{"system":"sec-edgar","filing":"0001415889-24-012239","document":"form4-05032024_060515.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924012239/form4-05032024_060515.xml","form_type":"4"}},{"id":1529063,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, HEAD OF COMMERCIAL"}}],"security":"Common Stock","published_at":"2024-05-03T22:00:48.000Z","date":"2024-05-02","kind":"sale","planned":false,"acquired":false,"shares":3477,"price":16.94,"value":58900.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.94 to $17.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":42133,"source":{"system":"sec-edgar","filing":"0001415889-24-012239","document":"form4-05032024_060515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924012239/form4-05032024_060515.xml","form_type":"4"}},{"id":1529062,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, HEAD OF COMMERCIAL"}}],"security":"Common Stock","published_at":"2024-05-03T22:00:48.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":true,"shares":6814,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":45610,"source":{"system":"sec-edgar","filing":"0001415889-24-012239","document":"form4-05032024_060515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924012239/form4-05032024_060515.xml","form_type":"4"}},{"id":1544770,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, HEAD OF COMMERCIAL"}}],"security":"Restricted Stock Units","published_at":"2024-04-09T22:00:13.000Z","date":"2024-04-05","kind":"exercise","planned":false,"acquired":false,"shares":5024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."}],"balance_after":10048,"derivative":{"underlying":"Common Stock","underlying_shares":5024},"source":{"system":"sec-edgar","filing":"0001415889-24-010603","document":"form4-04092024_060407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924010603/form4-04092024_060407.xml","form_type":"4"}},{"id":1544769,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, HEAD OF COMMERCIAL"}}],"security":"Common Stock","published_at":"2024-04-09T22:00:13.000Z","date":"2024-04-08","kind":"sale","planned":false,"acquired":false,"shares":2568,"price":17.87,"value":45890.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.7875 to $17.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":38796,"source":{"system":"sec-edgar","filing":"0001415889-24-010603","document":"form4-04092024_060407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924010603/form4-04092024_060407.xml","form_type":"4"}},{"id":1544768,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, HEAD OF COMMERCIAL"}}],"security":"Common Stock","published_at":"2024-04-09T22:00:13.000Z","date":"2024-04-05","kind":"exercise","planned":false,"acquired":true,"shares":5024,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":41364,"source":{"system":"sec-edgar","filing":"0001415889-24-010603","document":"form4-04092024_060407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924010603/form4-04092024_060407.xml","form_type":"4"}},{"id":1559840,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, HEAD OF COMMERCIAL"}}],"security":"Restricted Stock Units","published_at":"2024-03-28T00:00:16.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":27460,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning March 25, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning March 25, 2025."}],"balance_after":27460,"derivative":{"underlying":"Common Stock","underlying_shares":27460},"source":{"system":"sec-edgar","filing":"0001415889-24-009272","document":"form4-03272024_110355.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924009272/form4-03272024_110355.xml","form_type":"4"}},{"id":1559839,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, HEAD OF COMMERCIAL"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-03-28T00:00:16.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":89516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the Stock Option will vest and become exercisable on March 25, 2025. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":89516,"derivative":{"exercise_price":17.84,"expiration_date":"2034-03-24","underlying":"Common Stock","underlying_shares":89516},"source":{"system":"sec-edgar","filing":"0001415889-24-009272","document":"form4-03272024_110355.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924009272/form4-03272024_110355.xml","form_type":"4"}},{"id":1559838,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, HEAD OF COMMERCIAL"}}],"security":"Common Stock","published_at":"2024-03-28T00:00:16.000Z","date":"2024-03-27","kind":"sale","planned":false,"acquired":false,"shares":5140,"price":17.9,"value":92006.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of performance stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":36340,"source":{"system":"sec-edgar","filing":"0001415889-24-009272","document":"form4-03272024_110355.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924009272/form4-03272024_110355.xml","form_type":"4"}},{"id":1559837,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, HEAD OF COMMERCIAL"}}],"security":"Common Stock","published_at":"2024-03-28T00:00:16.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":10048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents acquisition of the Issuer's common stock upon vesting of the performance stock units granted to the Reporting Person on April 5, 2022 at 50% of target."}],"balance_after":41480,"source":{"system":"sec-edgar","filing":"0001415889-24-009272","document":"form4-03272024_110355.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924009272/form4-03272024_110355.xml","form_type":"4"}},{"id":1616814,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, HEAD OF COMMERCIAL"}}],"security":"Restricted Stock Units","published_at":"2024-02-27T23:10:33.000Z","date":"2024-02-23","kind":"exercise","planned":false,"acquired":false,"shares":1107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23, 2022."}],"balance_after":1107,"derivative":{"underlying":"Common Stock","underlying_shares":1107},"source":{"system":"sec-edgar","filing":"0001415889-24-005575","document":"form4-02272024_110225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924005575/form4-02272024_110225.xml","form_type":"4"}},{"id":1616813,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, HEAD OF COMMERCIAL"}}],"security":"Common Stock","published_at":"2024-02-27T23:10:33.000Z","date":"2024-02-26","kind":"sale","planned":false,"acquired":false,"shares":624,"price":24.67,"value":15394.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c)."}],"balance_after":31432,"source":{"system":"sec-edgar","filing":"0001415889-24-005575","document":"form4-02272024_110225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924005575/form4-02272024_110225.xml","form_type":"4"}},{"id":1616812,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, HEAD OF COMMERCIAL"}}],"security":"Common Stock","published_at":"2024-02-27T23:10:33.000Z","date":"2024-02-23","kind":"exercise","planned":false,"acquired":true,"shares":1107,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":32056,"source":{"system":"sec-edgar","filing":"0001415889-24-005575","document":"form4-02272024_110225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924005575/form4-02272024_110225.xml","form_type":"4"}},{"id":1683132,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Restricted Stock Units","published_at":"2024-01-09T23:00:33.000Z","date":"2024-01-06","kind":"exercise","planned":false,"acquired":false,"shares":1287,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third of the shares subject to the restricted stock units vest on each of January 6, 2022, January 6, 2023 and January 6, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"One-third of the shares subject to the restricted stock units vest on each of January 6, 2022, January 6, 2023 and January 6, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1287},"source":{"system":"sec-edgar","filing":"0001209191-24-001268","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919124001268/doc4.xml","form_type":"4"}},{"id":1683131,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Common Stock","published_at":"2024-01-09T23:00:33.000Z","date":"2024-01-08","kind":"sale","planned":false,"acquired":false,"shares":731,"price":29.96,"value":21900.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.61 to $29.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":30949,"source":{"system":"sec-edgar","filing":"0001209191-24-001268","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919124001268/doc4.xml","form_type":"4"}},{"id":1683130,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Common Stock","published_at":"2024-01-09T23:00:33.000Z","date":"2024-01-06","kind":"exercise","planned":false,"acquired":true,"shares":1287,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":31680,"source":{"system":"sec-edgar","filing":"0001209191-24-001268","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919124001268/doc4.xml","form_type":"4"}},{"id":1733270,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Restricted Stock Units","published_at":"2023-11-21T23:00:22.000Z","date":"2023-11-17","kind":"exercise","planned":false,"acquired":false,"shares":4956,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."}],"balance_after":19826,"derivative":{"underlying":"Common Stock","underlying_shares":4956},"source":{"system":"sec-edgar","filing":"0001209191-23-056355","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123056355/doc4.xml","form_type":"4"}},{"id":1733269,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Restricted Stock Units","published_at":"2023-11-21T23:00:22.000Z","date":"2023-11-17","kind":"exercise","planned":false,"acquired":false,"shares":4956,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."}],"balance_after":19826,"derivative":{"underlying":"Common Stock","underlying_shares":4956},"source":{"system":"sec-edgar","filing":"0001209191-23-056355","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123056355/doc4.xml","form_type":"4"}},{"id":1733268,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Common Stock","published_at":"2023-11-21T23:00:22.000Z","date":"2023-11-20","kind":"sale","planned":false,"acquired":false,"shares":4960,"price":22.64,"value":112294.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.64 to $22.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":30393,"source":{"system":"sec-edgar","filing":"0001209191-23-056355","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123056355/doc4.xml","form_type":"4"}},{"id":1733267,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Common Stock","published_at":"2023-11-21T23:00:22.000Z","date":"2023-11-17","kind":"exercise","planned":false,"acquired":true,"shares":4956,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":35353,"source":{"system":"sec-edgar","filing":"0001209191-23-056355","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123056355/doc4.xml","form_type":"4"}},{"id":1733266,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Common Stock","published_at":"2023-11-21T23:00:22.000Z","date":"2023-11-17","kind":"exercise","planned":false,"acquired":true,"shares":4956,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 707 and 378 shares of the Issuer's common stock acquired by the reporting person on May 15, 2023 and November 15, 2023, respectively, pursuant to an employee stock purchase program."}],"balance_after":30397,"source":{"system":"sec-edgar","filing":"0001209191-23-056355","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123056355/doc4.xml","form_type":"4"}},{"id":1885481,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Restricted Stock Units","published_at":"2023-05-19T22:43:20.000Z","date":"2023-05-17","kind":"exercise","planned":false,"acquired":false,"shares":14869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."}],"balance_after":24782,"derivative":{"underlying":"Common Stock","underlying_shares":14869},"source":{"system":"sec-edgar","filing":"0001209191-23-031241","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123031241/doc4.xml","form_type":"4"}},{"id":1885480,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Restricted Stock Units","published_at":"2023-05-19T22:43:20.000Z","date":"2023-05-17","kind":"exercise","planned":false,"acquired":false,"shares":14869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."}],"balance_after":24782,"derivative":{"underlying":"Common Stock","underlying_shares":14869},"source":{"system":"sec-edgar","filing":"0001209191-23-031241","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123031241/doc4.xml","form_type":"4"}},{"id":1885479,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Common Stock","published_at":"2023-05-19T22:43:20.000Z","date":"2023-05-17","kind":"sale","planned":false,"acquired":false,"shares":14869,"price":22.5,"value":334552.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":24356,"source":{"system":"sec-edgar","filing":"0001209191-23-031241","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123031241/doc4.xml","form_type":"4"}},{"id":1885478,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Common Stock","published_at":"2023-05-19T22:43:20.000Z","date":"2023-05-17","kind":"exercise","planned":false,"acquired":true,"shares":14869,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":39225,"source":{"system":"sec-edgar","filing":"0001209191-23-031241","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123031241/doc4.xml","form_type":"4"}},{"id":1885477,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Common Stock","published_at":"2023-05-19T22:43:20.000Z","date":"2023-05-17","kind":"exercise","planned":false,"acquired":true,"shares":14869,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":24356,"source":{"system":"sec-edgar","filing":"0001209191-23-031241","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123031241/doc4.xml","form_type":"4"}},{"id":1906757,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Restricted Stock Units","published_at":"2023-05-04T01:17:46.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":27259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."}],"balance_after":27259,"derivative":{"underlying":"Common Stock","underlying_shares":27259},"source":{"system":"sec-edgar","filing":"0001209191-23-027207","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123027207/doc4.xml","form_type":"4"}},{"id":1906756,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-05-04T01:17:46.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":89936,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on May 1, 2024. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":89936,"derivative":{"exercise_price":21.75,"expiration_date":"2033-05-01","underlying":"Common Stock","underlying_shares":89936},"source":{"system":"sec-edgar","filing":"0001209191-23-027207","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123027207/doc4.xml","form_type":"4"}},{"id":1909005,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Restricted Stock Units","published_at":"2023-05-02T23:04:58.000Z","date":"2023-04-29","kind":"exercise","planned":false,"acquired":false,"shares":1567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"50% of the shares subject to the restricted stock units vest on each of April 29, 2022 and April 29, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"50% of the shares subject to the restricted stock units vest on each of April 29, 2022 and April 29, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1567},"source":{"system":"sec-edgar","filing":"0001209191-23-026744","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123026744/doc4.xml","form_type":"4"}},{"id":1909004,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Common Stock","published_at":"2023-05-02T23:04:58.000Z","date":"2023-05-01","kind":"sale","planned":false,"acquired":false,"shares":548,"price":21.18,"value":11606.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":9487,"source":{"system":"sec-edgar","filing":"0001209191-23-026744","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123026744/doc4.xml","form_type":"4"}},{"id":1909003,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Common Stock","published_at":"2023-05-02T23:04:58.000Z","date":"2023-04-29","kind":"exercise","planned":false,"acquired":true,"shares":1567,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10035,"source":{"system":"sec-edgar","filing":"0001209191-23-026744","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123026744/doc4.xml","form_type":"4"}},{"id":1923199,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Restricted Stock Units","published_at":"2023-04-08T00:44:46.000Z","date":"2023-04-05","kind":"exercise","planned":false,"acquired":false,"shares":5024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."}],"balance_after":15072,"derivative":{"underlying":"Common Stock","underlying_shares":5024},"source":{"system":"sec-edgar","filing":"0001209191-23-023865","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123023865/doc4.xml","form_type":"4"}},{"id":1923198,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Common Stock","published_at":"2023-04-08T00:44:46.000Z","date":"2023-04-06","kind":"sale","planned":false,"acquired":false,"shares":1751,"price":18.16,"value":31798.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":8468,"source":{"system":"sec-edgar","filing":"0001209191-23-023865","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123023865/doc4.xml","form_type":"4"}},{"id":1923197,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Common Stock","published_at":"2023-04-08T00:44:46.000Z","date":"2023-04-05","kind":"exercise","planned":false,"acquired":true,"shares":5024,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":10219,"source":{"system":"sec-edgar","filing":"0001209191-23-023865","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123023865/doc4.xml","form_type":"4"}},{"id":1991066,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Restricted Stock Units","published_at":"2023-02-28T02:00:17.000Z","date":"2023-02-23","kind":"exercise","acquired":false,"shares":1107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23, 2022."}],"balance_after":2214,"derivative":{"underlying":"Common Stock","underlying_shares":1107},"source":{"system":"sec-edgar","filing":"0001209191-23-013468","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123013468/doc4.xml","form_type":"4"}},{"id":1991065,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Common Stock","published_at":"2023-02-28T02:00:17.000Z","date":"2023-02-24","kind":"sale","acquired":false,"shares":461,"price":18.78,"value":8657.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":5195,"source":{"system":"sec-edgar","filing":"0001209191-23-013468","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123013468/doc4.xml","form_type":"4"}},{"id":1991064,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Common Stock","published_at":"2023-02-28T02:00:17.000Z","date":"2023-02-23","kind":"exercise","acquired":true,"shares":1107,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":5656,"source":{"system":"sec-edgar","filing":"0001209191-23-013468","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123013468/doc4.xml","form_type":"4"}},{"id":2057915,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Restricted Stock Units","published_at":"2023-01-11T01:30:16.000Z","date":"2023-01-06","kind":"exercise","acquired":false,"shares":1286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One-third of the shares subject to the restricted stock units vest on each of January 6, 2022, January 6, 2023 and January 6, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"One-third of the shares subject to the restricted stock units vest on each of January 6, 2022, January 6, 2023 and January 6, 2024."}],"balance_after":1287,"derivative":{"underlying":"Common Stock","underlying_shares":1286},"source":{"system":"sec-edgar","filing":"0001209191-23-002895","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123002895/doc4.xml","form_type":"4"}},{"id":2057914,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Restricted Stock Units","published_at":"2023-01-11T01:30:16.000Z","date":"2022-01-06","kind":"exercise","acquired":false,"shares":1286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This restricted stock units is being re-reported solely to correct vesting terms on the Form 4 filed on January 10, 2022, which erroneously indicated that the restricted stock units vest in four equal annual installments beginning January 6, 2021.  The correct vesting is one-third of the shares subject to the restricted stock units vest on each of January 6, 2022, January 6, 2023 and January 6, 2024.  Except as noted in this footnote, all other information as disclosed in the Reporting Person's original Form 4 was accurately reported."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This restricted stock units is being re-reported solely to correct vesting terms on the Form 4 filed on January 10, 2022, which erroneously indicated that the restricted stock units vest in four equal annual installments beginning January 6, 2021.  The correct vesting is one-third of the shares subject to the restricted stock units vest on each of January 6, 2022, January 6, 2023 and January 6, 2024.  Except as noted in this footnote, all other information as disclosed in the Reporting Person's original Form 4 was accurately reported."}],"balance_after":2573,"derivative":{"underlying":"Common Stock","underlying_shares":1286},"source":{"system":"sec-edgar","filing":"0001209191-23-002895","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123002895/doc4.xml","form_type":"4"}},{"id":2057913,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Common Stock","published_at":"2023-01-11T01:30:16.000Z","date":"2023-01-09","kind":"sale","acquired":false,"shares":532,"price":17.1303,"value":9113.3196,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.13 to $17.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":4549,"source":{"system":"sec-edgar","filing":"0001209191-23-002895","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123002895/doc4.xml","form_type":"4"}},{"id":2057912,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Common Stock","published_at":"2023-01-11T01:30:16.000Z","date":"2023-01-06","kind":"exercise","acquired":true,"shares":1286,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 358 shares of the Issuer's common stock acquired by the reporting person on May 16, 2022 pursuant to an employee stock purchase program."}],"balance_after":5081,"source":{"system":"sec-edgar","filing":"0001209191-23-002895","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123002895/doc4.xml","form_type":"4"}},{"id":2284981,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Restricted Stock Units","published_at":"2022-05-04T00:47:20.000Z","date":"2022-04-29","kind":"exercise","acquired":false,"shares":1567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"50% of the shares subject to the restricted stock units vest on each of April 29, 2022 and April 29, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"50% of the shares subject to the restricted stock units vest on each of April 29, 2022 and April 29, 2023."}],"balance_after":1567,"derivative":{"underlying":"Common Stock","underlying_shares":1567},"source":{"system":"sec-edgar","filing":"0001209191-22-026937","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122026937/doc4.xml","form_type":"4"}},{"id":2284980,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Common Stock","published_at":"2022-05-04T00:47:20.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":552,"price":18.182,"value":10036.464,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.18 to $18.4025, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon\nrequest, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":3437,"source":{"system":"sec-edgar","filing":"0001209191-22-026937","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122026937/doc4.xml","form_type":"4"}},{"id":2284979,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Common Stock","published_at":"2022-05-04T00:47:20.000Z","date":"2022-04-29","kind":"exercise","acquired":true,"shares":1567,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."}],"balance_after":3989,"source":{"system":"sec-edgar","filing":"0001209191-22-026937","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122026937/doc4.xml","form_type":"4"}},{"id":2301763,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Restricted Stock Units","published_at":"2022-04-07T22:56:12.000Z","date":"2022-04-05","kind":"grant","acquired":true,"shares":20096,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."}],"balance_after":20096,"derivative":{"underlying":"Common Stock","underlying_shares":20096},"source":{"system":"sec-edgar","filing":"0001209191-22-023742","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122023742/doc4.xml","form_type":"4"}},{"id":2301762,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-04-07T22:56:12.000Z","date":"2022-04-05","kind":"grant","acquired":true,"shares":68966,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on April 5, 2023. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":68966,"derivative":{"exercise_price":25.75,"expiration_date":"2032-04-05","underlying":"Common Stock","underlying_shares":68966},"source":{"system":"sec-edgar","filing":"0001209191-22-023742","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122023742/doc4.xml","form_type":"4"}},{"id":2372889,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Restricted Stock Units","published_at":"2022-02-25T22:45:08.000Z","date":"2022-02-23","kind":"exercise","acquired":true,"shares":1106,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23 2022."}],"balance_after":3321,"derivative":{"underlying":"Common Stock","underlying_shares":1106},"source":{"system":"sec-edgar","filing":"0001209191-22-013284","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122013284/doc4.xml","form_type":"4"}},{"id":2372888,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Common Stock","published_at":"2022-02-25T22:45:08.000Z","date":"2022-02-23","kind":"sale","acquired":false,"shares":472,"price":23.8,"value":11233.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":2422,"source":{"system":"sec-edgar","filing":"0001209191-22-013284","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122013284/doc4.xml","form_type":"4"}},{"id":2372887,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Common Stock","published_at":"2022-02-25T22:45:08.000Z","date":"2022-02-23","kind":"exercise","acquired":true,"shares":1106,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2894,"source":{"system":"sec-edgar","filing":"0001209191-22-013284","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122013284/doc4.xml","form_type":"4"}},{"id":2439240,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Restricted Stock Units","published_at":"2022-01-10T23:25:32.000Z","date":"2022-01-06","kind":"exercise","acquired":false,"shares":1286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."}],"balance_after":2573,"derivative":{"underlying":"Common Stock","underlying_shares":1286},"source":{"system":"sec-edgar","filing":"0001209191-22-002751","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122002751/doc4.xml","form_type":"4"}},{"id":2439239,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Common Stock","published_at":"2022-01-10T23:25:32.000Z","date":"2022-01-06","kind":"sale","acquired":false,"shares":538,"price":23.05,"value":12400.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":1788,"source":{"system":"sec-edgar","filing":"0001209191-22-002751","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122002751/doc4.xml","form_type":"4"}},{"id":2439238,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Common Stock","published_at":"2022-01-10T23:25:32.000Z","date":"2022-01-06","kind":"exercise","acquired":true,"shares":1286,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 233 shares of the Issuer's common stock acquired by the reporting person on November 15, 2021 pursuant to an employee stock purchase program."}],"balance_after":2326,"source":{"system":"sec-edgar","filing":"0001209191-22-002751","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122002751/doc4.xml","form_type":"4"}},{"id":2503447,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Restricted Stock Units","published_at":"2021-11-19T23:35:42.000Z","date":"2021-11-17","kind":"grant","acquired":true,"shares":39651,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period."}],"balance_after":39651,"derivative":{"underlying":"Common Stock","underlying_shares":39651},"source":{"system":"sec-edgar","filing":"0001209191-21-065926","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121065926/doc4.xml","form_type":"4"}},{"id":2503446,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":66467,"kind":"person","name":"Teehan Brendan","position":1,"cik":"0001891900","reported_name":"Teehan Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, Head of Commercial"}}],"security":"Restricted Stock Units","published_at":"2021-11-19T23:35:42.000Z","date":"2021-11-17","kind":"grant","acquired":true,"shares":39651,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest as follows:  37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest as follows:  37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."}],"balance_after":39651,"derivative":{"underlying":"Common Stock","underlying_shares":39651},"source":{"system":"sec-edgar","filing":"0001209191-21-065926","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121065926/doc4.xml","form_type":"4"}}]}